Secondary use study of data from a multicenter, retrospective study on the efficacy and safety of fosravuconazole for the treatment of onychomycosis: A study on the elongation of healthy nails during foslavuconazole treatment

Secondary use study of data from a multicenter, retrospective study on the efficacy and safety of fosravuconazole for the treatment of onychomycosis: A study on the elongation of healthy nails during foslavuconazole treatment - Secondary use study of data from a multicenter, retrospective study on the efficacy and safety of fosravuconazole for the treatment of onychomycosis: A study on the elongation of healthy nails during foslavuconazole treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054941

Enrollment

108

Registered

2024-07-11

Start date

2023-12-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed as onychomycosis on either toenail of toe I to toe III by direct microscopy and/or fungal culture at the time of initiation of fosravuconazole treatment 2) Patients who started fosravuconazole treatment according to the medical package insert between June 1st, 2019 and April 30th, 2020

Exclusion criteria

Exclusion criteria: 1) Patients with significant nail thickening, deformity, or discoloration due to diseases such as palmoplantar pustulosis of the nails, psoriasis vulgaris, lichen planus of the nails, pachyonychia, tumor under the nails, onychogryphosis, etc. 2) Patients who have refused to provide medical information for this study

Design outcomes

Primary

Measure	Time frame
Elongation of healthy nails during foslavuconazole treatment	—

Secondary

Measure	Time frame
Change over time in nail involvement ratio during foslavuconazole treatment Exploration for factors affecting healthy nail elongation	—

Countries

Japan

Contacts

Public ContactWataru Naka

Naka Dermatology Clinic Dermatology

w-naka@kb4.so-net.ne.jp049-246-0039

Outcome results